The effect of magnesium sulfate and dexamethasone on upper limb anesthesia

Comparison of adding Magnesium Sulfate with low dose Dexamethasone on Ropivacaine solution in supraclavicular nerve plexus block for elective upper limb surgeries

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180325039148N3

Enrollment

Registered

2019-06-06

Start date

2019-06-22

Completion date

Unknown

Last updated

2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: The effect of adding magnesium sulfate and dexamethasone to ropivacaine on the quality of supraclavicular nerve block in hand and wrist injury. Condition 2: The effect of adding magnesium sulfate and dexamethasone to ropivacaine on the quality of supraclavicular nerve block in forearm injury. Fracture at wrist and hand level Fracture of forearm

Interventions

Intervention 1: Control group: 24cc Ropivacaine 0.5% + 1cc Normal Saline. Intervention 2: Intervention group: 24cc Ropivacaine 0.5% + 1 cc Dexamethasone 4mg. Intervention 3: Intervention group: 24cc R

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 18-65 Years old Candidates for elective upper limb surgery with ASA class I, II

Exclusion criteria

Exclusion criteria: Multiple trauma Diabetes Neuropathy Loss of consciousness Coagulopathy Broncopumonary diseases Psychiatric diseases Opium addiction Chronic using of analgesic Corticosteroid using at least in the recent year Positive past allergic history to Magnesium sulfate

Design outcomes

Primary

Measure	Time frame
Determination anesthesia and analgesia during surgery and postoperation period in hand surgeries. Timepoint: Beginnig of surgery_During of surgery_Recovery unit -up to 24 hours after surgey. Method of measurement: Visual Analogue Scale questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaeed Jalili

Zanjan University of Medical Sciences

jalilis45@zums.ac.ir+98 24 3313 0001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026